Quest Diagnostics Incorporated Stock Alpha and Beta Analysis

DGX Stock  USD 137.38  1.04  0.76%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Quest Diagnostics Incorporated. It also helps investors analyze the systematic and unsystematic risks associated with investing in Quest Diagnostics over a specified time horizon. Remember, high Quest Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Quest Diagnostics' market risk premium analysis include:
Beta
0.33
Alpha
0.1
Risk
1.33
Sharpe Ratio
0.13
Expected Return
0.18
Please note that although Quest Diagnostics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Quest Diagnostics did 0.10  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Quest Diagnostics Incorporated stock's relative risk over its benchmark. Quest Diagnostics has a beta of 0.33  . As returns on the market increase, Quest Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest Diagnostics is expected to be smaller as well. At this time, Quest Diagnostics' Book Value Per Share is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 3.00 in 2024, whereas Tangible Book Value Per Share is likely to drop (23.26) in 2024.

Quest Diagnostics Quarterly Cash And Equivalents

143 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Quest Diagnostics Backtesting, Quest Diagnostics Valuation, Quest Diagnostics Correlation, Quest Diagnostics Hype Analysis, Quest Diagnostics Volatility, Quest Diagnostics History and analyze Quest Diagnostics Performance.

Quest Diagnostics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Quest Diagnostics market risk premium is the additional return an investor will receive from holding Quest Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quest Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Quest Diagnostics' performance over market.
α0.10   β0.33

Quest Diagnostics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Quest Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Quest Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Quest Diagnostics Market Price Analysis

Market price analysis indicators help investors to evaluate how Quest Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quest Diagnostics shares will generate the highest return on investment. By understating and applying Quest Diagnostics stock market price indicators, traders can identify Quest Diagnostics position entry and exit signals to maximize returns.

Quest Diagnostics Return and Market Media

The median price of Quest Diagnostics for the period between Mon, Feb 5, 2024 and Sun, May 5, 2024 is 128.14 with a coefficient of variation of 3.2. The daily time series for the period is distributed with a sample standard deviation of 4.12, arithmetic mean of 128.87, and mean deviation of 3.24. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
AI Infrastructure Takes Center Stage At GTC 2024
03/27/2024
2
Sequoia Financial Advisors LLC Buys New Position in Quest Diagnostics Incorporated - MarketBeat
04/12/2024
 
Quest Diagnostics dividend paid on 22nd of April 2024
04/22/2024
3
Quest Diagnostics Q1 Earnings Top Estimates, Margins Down
04/23/2024
4
The corporate conversation around AI is changing Morning Brief
04/24/2024
5
Freenome to cut more than 100 employees in restructuring
04/25/2024
6
Worlds Most Powerful AI GPU OpenAI Receives Nvidias DGX H200 for Advancing AGI Research
04/26/2024
7
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
04/29/2024
8
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis Forms Licensing Agreements with PathAI
05/01/2024
9
Quest Diagnostics Inks Deal to Acquire PathAI Diagnostics
05/02/2024

About Quest Diagnostics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Quest or other stocks. Alpha measures the amount that position in Quest Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.01430.01680.02030.0214
Price To Sales Ratio2.01.841.671.13

Quest Diagnostics Upcoming Company Events

As portrayed in its financial statements, the presentation of Quest Diagnostics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Quest Diagnostics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Quest Diagnostics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Quest Diagnostics. Please utilize our Beneish M Score to check the likelihood of Quest Diagnostics' management manipulating its earnings.
1st of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Quest Diagnostics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:
Check out Quest Diagnostics Backtesting, Quest Diagnostics Valuation, Quest Diagnostics Correlation, Quest Diagnostics Hype Analysis, Quest Diagnostics Volatility, Quest Diagnostics History and analyze Quest Diagnostics Performance.
Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Quest Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Quest Diagnostics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Quest Diagnostics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...